• 1. Enabling chloride salts for thermal energy storage: implications of salt purity?
  J. Matthew Kurley,Phillip W. Halstenberg,Abbey McAlister,Stephen Raiman,Richard T. Mayes RSC Adv., 2019,9, 25602-25608
• 2. Examination of deposit in commercial diluted phosphoric acid
  Analyst, 1880,5, 146-147
• 3. Excellent lithium ion storage property of porous MnCo2O4 nanorods?
  Peiyuan Zeng,Xiaoxiao Wang,Ming Ye,Qiuyang Ma,Jianwen Li,Wanwan Wang,Baoyou Geng,Zhen Fang RSC Adv., 2016,6, 23074-23084
• 4. Excimer emission and magnetoluminescence of radical-based zinc(ii) complexes doped in host crystals?
  Shojiro Kimura,Tetsuro Kusamoto Chem. Commun., 2020,56, 11195-11198
• 5. Distinction of trans–cis photoisomers with comparable optical properties in multiple-state photochromic systems – examining a molecule with three azobenzenes via in situ irradiation NMR spectroscopy?
  Jonas Kind,Lukas Kaltschnee,Martin Leyendecker,Christina M. Thiele Chem. Commun., 2016,52, 12506-12509

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Piperidines Piperidines
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Piperidines

Introduction to Tert-butyl N-{[(3R,4S)-3-fluoropiperidin-4-yl)methyl}carbamate (CAS No. 1932074-14-0)

Tert-butyl N-{[(3R,4S)-3-fluoropiperidin-4-yl)methyl}carbamate, identified by its CAS number 1932074-14-0, is a significant compound in the field of pharmaceutical chemistry. This compound belongs to a class of molecules that exhibit promising biological activities, making it a subject of extensive research and development. The structure of this molecule incorporates a tert-butyl group, which is known for its steric hindrance properties, and a piperidine ring substituted with a fluorine atom, contributing to its unique chemical and pharmacological characteristics.

The piperidine moiety in Tert-butyl N-{[(3R,4S)-3-fluoropiperidin-4-yl)methyl}carbamate is particularly noteworthy due to its presence in numerous bioactive agents. Piperidine derivatives are widely recognized for their role in central nervous system (CNS) drugs, where they often serve as key structural elements that influence pharmacokinetic and pharmacodynamic properties. The specific configuration of the piperidine ring, with the (3R,4S) stereochemistry, is crucial as it determines the molecule's interaction with biological targets. This stereochemical purity is often achieved through advanced synthetic methodologies that ensure high enantiomeric excess.

The introduction of a fluorine atom at the 3-position of the piperidine ring in Tert-butyl N-{[(3R,4S)-3-fluoropiperidin-4-yl)methyl}carbamate enhances its metabolic stability and binding affinity to biological receptors. Fluorine atoms are frequently employed in drug design due to their ability to modulate electronic properties and improve lipophilicity, which can lead to better oral bioavailability and prolonged half-life. The combination of these structural features makes this compound an attractive candidate for further investigation in medicinal chemistry.

In recent years, there has been growing interest in the development of novel therapeutic agents targeting neurological disorders. Tert-butyl N-{[(3R,4S)-3-fluoropiperidin-4-yl)methyl}carbamate has been explored as a potential lead compound in this context. Preclinical studies have demonstrated its efficacy in models of cognitive impairment and neurodegenerative diseases. The carbamate functional group contributes to the molecule's ability to interact with specific enzymes and receptors involved in these pathologies. Additionally, the tert-butyl group provides steric protection, which can prevent unwanted side reactions and enhance selectivity.

The synthesis of Tert-butyl N-{[(3R,4S)-3-fluoropiperidin-4-yl)methyl}carbamate involves multi-step organic reactions that require precise control over reaction conditions and stereochemistry. Advanced techniques such as chiral resolution and asymmetric synthesis are employed to achieve the desired stereochemical purity. The fluorinated piperidine core is typically constructed through nucleophilic substitution reactions or cross-coupling methodologies, which allow for the introduction of fluorine atoms at specific positions with high fidelity.

One of the most compelling aspects of Tert-butyl N-{[(3R,4S)-3-fluoropiperidin-4-yl)methyl}carbamate is its potential for further derivatization. By modifying various functional groups within its structure, researchers can explore new analogs with enhanced pharmacological properties. For instance, replacing the carbamate group with other bioisosteric moieties could alter the molecule's solubility profile or metabolic stability without compromising its biological activity. Such modifications are essential for optimizing drug candidates for clinical use.

The pharmaceutical industry has increasingly recognized the importance of fluorinated piperidine derivatives in drug development. These compounds have shown promise in treating a wide range of diseases, including cancer, inflammation, and infectious disorders. Tert-butyl N-{[(3R,4S)-3-fluoropiperidin-4-yl)methyl}carbamate exemplifies how structural innovation can lead to novel therapeutic entities with significant clinical potential. Its unique combination of stereochemical purity and functional group diversity positions it as a valuable building block for future drug discovery efforts.

Ongoing research into Tert-butyl N-{[(3R,4S)-3-fluoropiperidin-4-yl)methyl}carbamate continues to uncover new insights into its mechanism of action and potential therapeutic applications. Collaborative efforts between academic institutions and pharmaceutical companies are driving innovation in this area by leveraging cutting-edge computational methods and experimental techniques. As our understanding of biological pathways improves, compounds like this one will play an increasingly important role in developing next-generation treatments for complex diseases.

In conclusion, Tert-butyl N-{[(3R,4S)-3-fluoropiperidin-4-yl)methyl}carbamate (CAS No. 1932074-14-0) represents a significant advancement in pharmaceutical chemistry. Its unique structural features make it a versatile tool for drug discovery and development. With continued research and innovation, this compound holds great promise for addressing unmet medical needs across various therapeutic areas.

• 871022-62-7(tert-butyl N-[(4-fluoropiperidin-4-yl)methyl]carbamate)
• 1334416-43-1(tert-butyl 4-(aMinoMethyl)-3-fluoro-4-Methylpiperidine-1-carboxylate)
• 1303972-96-4(tert-butyl 4-(aminomethyl)-3-fluoropiperidine-1-carboxylate)
• 1250998-80-1(tert-Butyl 5-fluoro-2,7-diazaspiro[3.5]nonane-7-carboxylate)
• 1237526-35-0(tert-butyl cis-4-(aminomethyl)-3-fluoro-piperidine-1-carboxylate)
• 1263178-67-1(tert-butyl 5-fluoro-2,7-diazaspiro[3.5]nonane-2-carboxylate)
• 1404196-62-8(di-tert-butyl4,4'-azanediylbis(methylene)bis(3-fluoro-4-methylpiperidine-1-carboxylate)-D28120)
• 1408076-00-5(tert-butyl N-[[cis-3-fluoro-4-piperidyl]methyl]carbamate)
• 2165962-90-1(tert-butyl N-{[(3S,4R)-3-fluoropiperidin-4-yl]methyl}carbamate)
• 1262408-83-2(tert-butyl N-[(3-fluoropiperidin-3-yl)methyl]carbamate)